BOXER: A multicentre phase II trial of capecitabine and oxaliplatin plus bevacizumab as neoadjuvant treatment for patients with liver-only metastases from colorectal cancer unsuitable for upfront resection
Authors: Wong, R., Saffery, C., Barbachano, Y., Chau, I., Valle, J., Hickish, T., Mudan, S., Khan, A., Chua, Y.J. and Cunningham, D.
Journal: EJC SUPPLEMENTS
Volume: 7
Issue: 2
Pages: 344-345
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71171-1
Source: Web of Science (Lite)
Preferred by: Tamas Hickish